Исследование полиморфных вариантов генов, участвующих в метаболизме бета-2-агонистов и гистамина, в развитии и течении бронхиальной астмы

Asthma is one of the most common severe and disabling chronic diseases. It has been shown that up to 50-60% of sensitivity to asthma therapy is due to genetic variability. The study of polymorphisms of genes involved in the metabolism of beta-2-agonists (CRHR2, ADCY9, THRB, SPATS2L) and histamine (AOC1, HRH4) in asthma patients and individuals of the control group of different ethnicities were carried out.